LU86785A1 - Procede de preparation d'encainide - Google Patents

Procede de preparation d'encainide Download PDF

Info

Publication number
LU86785A1
LU86785A1 LU86785A LU86785A LU86785A1 LU 86785 A1 LU86785 A1 LU 86785A1 LU 86785 A LU86785 A LU 86785A LU 86785 A LU86785 A LU 86785A LU 86785 A1 LU86785 A1 LU 86785A1
Authority
LU
Luxembourg
Prior art keywords
methyl
iii
hydrochloride
encainide
sulfate
Prior art date
Application number
LU86785A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU86785A1 publication Critical patent/LU86785A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02—Preparation by ring-closure or hydrogenation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
LU86785A 1986-02-25 1987-02-24 Procede de preparation d'encainide LU86785A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/833,295 US4675409A (en) 1986-02-25 1986-02-25 Process for the preparation of encainide
US83329586 1986-02-25

Publications (1)

Publication Number Publication Date
LU86785A1 true LU86785A1 (fr) 1987-09-15

Family

ID=25264016

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86785A LU86785A1 (fr) 1986-02-25 1987-02-24 Procede de preparation d'encainide

Country Status (23)

Country Link
US (1) US4675409A (de)
JP (1) JPS62240659A (de)
KR (1) KR900001203B1 (de)
AT (1) AT394716B (de)
AU (1) AU597939B2 (de)
BE (1) BE1000112A5 (de)
CA (1) CA1291483C (de)
CH (1) CH671223A5 (de)
DE (1) DE3705664A1 (de)
DK (1) DK94487A (de)
ES (2) ES2002637A6 (de)
FI (1) FI85853C (de)
FR (1) FR2595353B1 (de)
GB (1) GB2187189B (de)
GR (1) GR870281B (de)
HU (1) HU196960B (de)
IL (1) IL81657A0 (de)
IT (1) IT1203501B (de)
LU (1) LU86785A1 (de)
NL (1) NL8700452A (de)
PT (1) PT84348B (de)
SE (1) SE464301B (de)
ZA (1) ZA871334B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800226A (en) * 1986-02-25 1989-01-24 Bristol-Myers Company Process intermediate for the preparation of encainide
BRPI0618790A2 (pt) * 2005-11-17 2011-09-13 Novartis Ag compostos orgánicos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064254A (en) * 1971-03-03 1977-12-20 Mead Johnson & Company Substituted piperidines therapeutic process and compositions
CA961038A (en) * 1971-03-03 1975-01-14 Joseph L. Minielli Substituted piperidines
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US4000143A (en) * 1971-03-03 1976-12-28 Mead Johnson & Company Substituted piperidines
US4394507A (en) * 1981-12-14 1983-07-19 Mead Johnson & Company Process for production of encainide

Also Published As

Publication number Publication date
JPS62240659A (ja) 1987-10-21
KR900001203B1 (ko) 1990-02-28
FR2595353B1 (fr) 1990-11-30
FI870767A0 (fi) 1987-02-23
GR870281B (en) 1987-06-30
DE3705664C2 (de) 1989-09-28
DK94487D0 (da) 1987-02-24
SE464301B (sv) 1991-04-08
GB2187189A (en) 1987-09-03
HUT43563A (en) 1987-11-30
BE1000112A5 (fr) 1988-03-29
PT84348B (pt) 1989-09-14
AU6924687A (en) 1987-08-27
CA1291483C (en) 1991-10-29
GB2187189B (en) 1990-01-10
FI85853C (fi) 1992-06-10
PT84348A (en) 1987-03-01
AT394716B (de) 1992-06-10
NL8700452A (nl) 1987-09-16
KR870007887A (ko) 1987-09-22
SE8700776D0 (sv) 1987-02-24
ATA41287A (de) 1991-11-15
CH671223A5 (de) 1989-08-15
FI870767A (fi) 1987-08-26
ES2002637A6 (es) 1988-09-01
ZA871334B (en) 1987-10-28
DE3705664A1 (de) 1987-08-27
AU597939B2 (en) 1990-06-14
US4675409A (en) 1987-06-23
FR2595353A1 (fr) 1987-09-11
IL81657A0 (en) 1987-09-16
SE8700776L (sv) 1987-08-26
ES2007062A6 (es) 1989-06-01
IT1203501B (it) 1989-02-15
DK94487A (da) 1987-08-26
IT8719475A0 (it) 1987-02-24
GB8703882D0 (en) 1987-03-25
FI85853B (fi) 1992-02-28
HU196960B (en) 1989-02-28

Similar Documents

Publication Publication Date Title
EP0591057B1 (de) Arylalkyl(thio)amide mit Melatonin-Rezeptor-Selektivität und Prozess zu ihrer Darstellung
EP0373998B1 (de) Propenonoximether, Verfahren zu dessen Herstellung sowie diese enthaltende Arzneinmittel
CA1116611A (en) Imidazole derivatives exhibiting anticonvulsant activity
JPS6012350B2 (ja) 新規アリ−ルピペリジン誘導体の製造方法
FR2582309A1 (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
EP1214313B1 (de) Heteroaryloxypropanolamine als beta3-adrenergischer rezeptor-agonisten
EP0213984B1 (de) Indolcarboxamidderivate, ihre Salze, Verfahren und Zwischenprodukte, Anwendung als Heilmittel und Zusammensetzungen die sie enthalten
FR2595695A1 (fr) Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
EP0077427B1 (de) Piperidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0002978B1 (de) Thiazolidindion-2,4 Derivate, deren Herstellung und Verwendung als Arzneimittel
BE1000112A5 (fr) Procede de preparation d'encainide.
EP0612716B1 (de) Verfahren zur Herstellung von einem optisch reinen Aminoalkohol
FI77017C (fi) Foerfarande foer framstaellning av fenyletanolaminer.
US4800226A (en) Process intermediate for the preparation of encainide
EP0275762B1 (de) Indol-Carboxamid-Derivate und ihre Salze, Verfahren und Zwischenprodukte zur Herstellung, Anwendung als Heilmittel und Zusammenstellungen, die sie enthalten
JPH02172956A (ja) エリスロ―３―（３，４―ジヒドロキシフェニル）セリン誘導体の新規製造法
US5442120A (en) Production of dobutamine compounds
EP2938595B1 (de) Verfahren zur synthese eines hydrazin zur behandlung des papillomavirus
CA1266050A (fr) Procede de preparation de nouveaux derives de l'indole carboxamide et de leurs sels
KR790001666B1 (ko) 9,10-에타노-9,10-디히드로안트라센 유도체의 제조방법
GB2067195A (en) 2-aminomethyl-6-halo-phenols their production and pharmaceutical composition containing them
CH376491A (fr) Procédé de préparation de triphényléthylènes substitués
FR2595357A1 (fr) (piperidino-3 propoxy)-5 p.cymene, les derives acetyl, acetoxy et hydroxy dudit produit, les sels de ces produits, un procede de preparation desdits produits et les medicaments contenant au moins un de ces produits comme principe actif
BE562169A (de)
JP2003261524A (ja) アミノ化合物類ならびにその立体選択的製造方法